| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.855 | 0.003 | 0.871 | Butyrylcholinesterase inhibitor | 0.676 0.003 DBMET00901 0.871 0.002 DBMET00902 0.738 0.003 DBMET00903 | DBMET00902 | |
| 0.829 | 0.003 | 0.852 | Immunosuppressant | 0.746 0.004 DBMET00901 0.852 0.003 DBMET00902 0.811 0.003 DBMET00903 | DBMET00902 | |
| 0.754 | 0.009 | 0.877 | Cyclophilin D inhibitor | 0.877 0.005 DBMET00902 0.796 0.007 DBMET00903 | DBMET00902 | |
| 0.719 | 0.004 | 0.719 | Cholinergic | 0.668 0.004 DBMET00901 0.71 0.004 DBMET00902 0.62 0.005 DBMET00903 | ||
| 0.7 | 0.004 | 0.713 | Acetylcholinesterase inhibitor | 0.67 0.004 DBMET00901 0.713 0.004 DBMET00902 0.607 0.004 DBMET00903 | DBMET00902 | |
| 0.506 | 0.004 | 0.591 | Aldehyde dehydrogenase inhibitor | 0.18 0.033 DBMET00901 0.443 0.005 DBMET00902 0.591 0.004 DBMET00903 | DBMET00903 | |
| 0.286 | 0.004 | 0.296 | Thioredoxin inhibitor | 0.296 0.003 DBMET00902 0.268 0.004 DBMET00903 | DBMET00902 | |
| 0.313 | 0.083 | 0.379 | Cholesterol antagonist | 0.354 0.063 DBMET00901 0.267 0.113 DBMET00902 0.379 0.054 DBMET00903 | DBMET00903 | |
| 0.238 | 0.056 | 0.413 | Anesthetic general | 0.413 0.015 DBMET00901 0.148 0.116 DBMET00902 0.256 0.048 DBMET00903 | DBMET00901 | |
| 0.247 | 0.071 | 0.274 | Tyrosine 3 hydroxylase inhibitor | 0.247 0.071 DBMET00901 0.243 0.075 DBMET00902 0.274 0.048 DBMET00903 | DBMET00903 | |
| 0.294 | 0.127 | 0.391 | Histamine release inhibitor | 0.363 0.094 DBMET00901 0.391 0.08 DBMET00903 | DBMET00903 | |
| 0.191 | 0.042 | 0.201 | Arachidonic acid antagonist | 0.201 0.032 DBMET00901 0.183 0.051 DBMET00902 0.195 0.038 DBMET00903 | DBMET00901 | |
| 0.162 | 0.026 | 0.222 | Mucolytic | 0.222 0.009 DBMET00901 0.203 0.013 DBMET00902 0.203 0.013 DBMET00903 | DBMET00901 | |
| 0.147 | 0.037 | 0.23 | Expectorant | 0.23 0.015 DBMET00901 0.207 0.019 DBMET00902 0.203 0.02 DBMET00903 | DBMET00901 | |
| 0.173 | 0.076 | 0.246 | Succinate dehydrogenase inhibitor | 0.173 0.076 DBMET00901 0.231 0.03 DBMET00902 0.246 0.024 DBMET00903 | DBMET00903 | |
| 0.174 | 0.085 | 0.211 | Hepatoprotectant | 0.186 0.075 DBMET00901 0.211 0.059 DBMET00902 0.189 0.072 DBMET00903 | DBMET00902 | |
| 0.156 | 0.068 | 0.204 | Phospholipase A2 inhibitor | 0.175 0.057 DBMET00901 0.15 0.074 DBMET00902 0.204 0.04 DBMET00903 | DBMET00903 | |
| 0.2 | 0.12 | 0.432 | Immunostimulant | 0.432 0.041 DBMET00901 0.199 0.121 DBMET00902 0.245 0.098 DBMET00903 | DBMET00901 | |
| 0.065 | 0.024 | 0.205 | Angiotensin-converting enzyme inhibitor | 0.205 0.004 DBMET00901 0.07 0.019 DBMET00902 0.071 0.019 DBMET00903 | DBMET00901 | |
| 0.133 | 0.102 | 0.138 | Ca2+-transporting ATPase inhibitor | 0.133 0.102 DBMET00901 0.138 0.08 DBMET00902 0.133 0.101 DBMET00903 | DBMET00902 | |
| 0.076 | 0.05 | 0.146 | Catalase inhibitor | 0.098 0.039 DBMET00901 0.113 0.035 DBMET00902 0.146 0.027 DBMET00903 | DBMET00903 | |
| 0.068 | 0.043 | 0.092 | Glutamate (mGluR6) antagonist | 0.078 0.027 DBMET00901 0.085 0.019 DBMET00902 0.092 0.014 DBMET00903 | DBMET00903 | |
| 0.032 | 0.009 | 0.047 | Lysophosphatidic acid receptor 1 agonist | 0.047 0.004 DBMET00901 0.028 0.013 DBMET00902 0.031 0.01 DBMET00903 | DBMET00901 | |
| 0.074 | 0.051 | 0.112 | Glutamate dehydrogenase inhibitor | 0.091 0.036 DBMET00901 0.112 0.025 DBMET00902 0.107 0.027 DBMET00903 | DBMET00902 | |
| 0.052 | 0.029 | 0.06 | Collagenase inhibitor | 0.055 0.022 DBMET00901 0.06 0.015 DBMET00902 0.051 0.029 DBMET00903 | DBMET00902 | |
| 0.109 | 0.09 | 0.214 | Alpha-N-acetylglucosaminidase inhibitor | 0.109 0.09 DBMET00901 0.214 0.03 DBMET00902 0.163 0.048 DBMET00903 | DBMET00902 | |
| 0.098 | 0.08 | 0.127 | GABA C receptor antagonist | 0.126 0.047 DBMET00901 0.127 0.046 DBMET00902 0.109 0.065 DBMET00903 | DBMET00902 | |
| 0.054 | 0.038 | 0.071 | Acyl-CoA dehydrogenase inhibitor | 0.071 0.026 DBMET00901 0.057 0.035 DBMET00902 0.071 0.026 DBMET00903 | DBMET00903 | |
| 0.049 | 0.037 | 0.06 | Lysophosphatidic acid 3 receptor antagonist | 0.06 0.023 DBMET00901 0.046 0.043 DBMET00902 0.053 0.031 DBMET00903 | DBMET00901 | |
| 0.018 | 0.006 | 0.032 | Lysophosphatidic acid receptor 3 agonist | 0.032 0.003 DBMET00901 0.013 0.009 DBMET00903 | DBMET00901 | |
| 0.082 | 0.071 | 0.082 | Granulocyte macrophage colony stimulating factor agonist | 0.082 0.071 DBMET00901 | ||
| 0.019 | 0.009 | 0.02 | Carbonic anhydrase X inhibitor | 0.019 0.009 DBMET00901 0.016 0.013 DBMET00902 0.02 0.008 DBMET00903 | DBMET00903 | |
| 0.019 | 0.009 | 0.02 | Carbonic anhydrase VIII inhibitor | 0.019 0.009 DBMET00901 0.016 0.013 DBMET00902 0.02 0.008 DBMET00903 | DBMET00903 | |
| 0.045 | 0.038 | 0.081 | Glucose-6-phosphate isomerase inhibitor | 0.052 0.026 DBMET00901 0.081 0.008 DBMET00902 0.065 0.015 DBMET00903 | DBMET00902 | |
| 0.049 | 0.057 | 0.134 | Carbamoyl phosphate synthetase inhibitor | 0.063 0.04 DBMET00901 0.134 0.013 DBMET00902 0.092 0.023 DBMET00903 | DBMET00902 | |
| 0.142 | 0.155 | 0.178 | Free radical scavenger | 0.178 0.116 DBMET00902 0.16 0.133 DBMET00903 | DBMET00902 | |
| 0.075 | 0.088 | 0.155 | Aminopeptidase B inhibitor | 0.097 0.067 DBMET00901 0.155 0.036 DBMET00902 0.128 0.048 DBMET00903 | DBMET00902 | |
| 0.043 | 0.057 | 0.071 | Alcohol oxidase inhibitor | 0.062 0.034 DBMET00902 0.071 0.028 DBMET00903 | DBMET00903 | |
| 0.011 | 0.027 | 0.021 | Purinergic P2T antagonist | 0.019 0.017 DBMET00902 0.021 0.015 DBMET00903 | DBMET00903 | |
| 0.015 | 0.032 | 0.021 | Methylmalonyl-CoA mutase inhibitor | 0.021 0.007 DBMET00902 0.017 0.015 DBMET00903 | DBMET00902 | |
| 0.094 | 0.114 | 0.21 | Bone formation stimulant | 0.21 0.033 DBMET00901 0.138 0.069 DBMET00903 | DBMET00901 | |
| 0.015 | 0.037 | 0.05 | Purinergic P2X agonist | 0.05 0.009 DBMET00901 | DBMET00901 | |
| 0.09 | 0.112 | 0.098 | Photosensitizer | 0.098 0.092 DBMET00903 | DBMET00903 | |
| 0.196 | 0.218 | 0.766 | 15-Lipoxygenase inhibitor | 0.766 0.008 DBMET00901 | DBMET00901 | |
| 0.005 | 0.029 | 0.014 | Purinergic receptor agonist | 0.014 0.011 DBMET00901 | DBMET00901 | |
| 0.005 | 0.029 | 0.014 | Purinergic P2 agonist | 0.014 0.011 DBMET00901 | DBMET00901 | |
| 0.03 | 0.054 | 0.066 | Glutamate (mGluR8) agonist | 0.066 0.005 DBMET00902 0.042 0.02 DBMET00903 | DBMET00902 | |
| 0.074 | 0.102 | 0.093 | UDP-glucose 4-epimerase inhibitor | 0.093 0.07 DBMET00901 | DBMET00901 | |
| 0.024 | 0.053 | 0.041 | AMPA receptor agonist | 0.041 0.017 DBMET00902 | DBMET00902 | |
| 0.053 | 0.084 | 0.209 | Glutamate decarboxylase inhibitor | 0.209 0.006 DBMET00902 0.097 0.031 DBMET00903 | DBMET00902 | |
| 0.044 | 0.079 | 0.138 | Phosphofructokinase-1 inhibitor | 0.06 0.057 DBMET00901 0.138 0.02 DBMET00902 0.094 0.034 DBMET00903 | DBMET00902 | |
| 0.138 | 0.181 | 0.167 | Antioxidant | 0.167 0.145 DBMET00903 | DBMET00903 | |
| 0.035 | 0.079 | 0.082 | Aconitate hydratase inhibitor | 0.082 0.013 DBMET00902 0.061 0.025 DBMET00903 | DBMET00902 | |
| 0.018 | 0.063 | 0.064 | Fumarate hydratase inhibitor | 0.064 0.009 DBMET00902 0.035 0.023 DBMET00903 | DBMET00902 | |
| 0.066 | 0.113 | 0.143 | Triose-phosphate isomerase inhibitor | 0.079 0.077 DBMET00901 0.143 0.022 DBMET00902 0.105 0.043 DBMET00903 | DBMET00902 | |
| 0.004 | 0.053 | 0.016 | Glutamate (mGluR6) agonist | 0.016 0.005 DBMET00902 | DBMET00902 | |
| 0.085 | 0.135 | 0.107 | Toll-Like receptor 2 antagonist | 0.107 0.094 DBMET00901 | DBMET00901 | |
| 0.077 | 0.128 | 0.138 | Adenylate kinase inhibitor | 0.09 0.087 DBMET00901 0.138 0.032 DBMET00902 0.108 0.056 DBMET00903 | DBMET00902 | |
| 0.021 | 0.082 | 0.037 | Carboxypeptidase B inhibitor | 0.037 0.016 DBMET00902 | DBMET00902 | |
| 0.146 | 0.208 | 0.451 | Lipoxygenase inhibitor | 0.451 0.026 DBMET00901 | DBMET00901 | |
| 0.045 | 0.108 | 0.103 | Aminopeptidase I inhibitor | 0.103 0.026 DBMET00902 0.073 0.05 DBMET00903 | DBMET00902 | |
| 0.071 | 0.147 | 0.092 | Toll-Like receptor 4 antagonist | 0.092 0.085 DBMET00901 | DBMET00901 | |
| 0.02 | 0.105 | 0.036 | Membrane dipeptidase inhibitor | 0.036 0.032 DBMET00902 | DBMET00902 | |
| 0.02 | 0.105 | 0.051 | Ornithine carbamoyltransferase inhibitor | 0.051 0.039 DBMET00902 | DBMET00902 | |
| 0.009 | 0.11 | 0.037 | Lysine carboxypeptidase inhibitor | 0.037 0.012 DBMET00902 | DBMET00902 | |
| 0.057 | 0.158 | 0.095 | NADH dehydrogenase inhibitor | 0.095 0.05 DBMET00902 | DBMET00902 | |
| 0.028 | 0.135 | 0.12 | Peroxisome proliferator-activated receptor gamma agonist | 0.12 0.02 DBMET00902 0.068 0.05 DBMET00903 | DBMET00902 | |
| 0.023 | 0.132 | 0.077 | Argininosuccinate synthase inhibitor | 0.077 0.027 DBMET00902 | DBMET00902 | |
| 0.024 | 0.148 | 0.084 | Biliverdin reductase inhibitor | 0.084 0.024 DBMET00902 | DBMET00902 | |
| 0.047 | 0.197 | 0.26 | GABA C receptor agonist | 0.26 0.012 DBMET00902 0.09 0.079 DBMET00903 | DBMET00902 | |
| 0.045 | 0.212 | 0.112 | Chelator | 0.112 0.062 DBMET00901 0.107 0.068 DBMET00902 | DBMET00901 | |
| 0.049 | 0.24 | 0.19 | Thrombolytic | 0.19 0.057 DBMET00902 0.137 0.093 DBMET00903 | DBMET00902 | |
| 0.044 | 0.236 | 0.108 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.108 0.047 DBMET00902 | DBMET00902 | |
| 0.021 | 0.225 | 0.108 | Porphobilinogen synthase inhibitor | 0.108 0.033 DBMET00902 | DBMET00902 | |
| 0.053 | 0.257 | 0.103 | DOPA decarboxylase inhibitor | 0.103 0.07 DBMET00902 | DBMET00902 | |
| 0.005 | 0.22 | 0.038 | Purinergic P2Y12 antagonist | 0.038 0.009 DBMET00901 | DBMET00901 | |
| 0.036 | 0.263 | 0.156 | Ferrochelatase inhibitor | 0.156 0.035 DBMET00902 | DBMET00902 | |
| 0.065 | 0.298 | 0.171 | Hypolipemic | 0.171 0.117 DBMET00901 | DBMET00901 | |
| 0.045 | 0.312 | 0.078 | D-Ala-D-Ala ligase inhibitor | 0.078 0.075 DBMET00902 | DBMET00902 | |
| 0.07 | 0.37 | 0.356 | Thyroid hormone antagonist | 0.356 0.071 DBMET00901 | DBMET00901 | |
| 0.049 | 0.38 | 0.43 | Platelet adhesion inhibitor | 0.43 0.009 DBMET00901 | DBMET00901 | |
| 0.038 | 0.424 | 0.212 | Platelet antagonist | 0.212 0.093 DBMET00901 | DBMET00901 | |
| 0.085 | 0.48 | 0.209 | Apoptosis antagonist | 0.209 0.168 DBMET00901 | DBMET00901 | |
| 0.015 | 0.462 | 0.064 | Autotaxin inhibitor | 0.064 0.026 DBMET00901 | DBMET00901 | |
| 0.004 | 0.618 | 0.041 | Integrin alphaVbeta1 antagonist | 0.041 0.005 DBMET00902 | DBMET00902 | |
| 0.046 | 0.67 | 0.216 | Sodium/bile acid cotransporter inhibitor | 0.216 0.166 DBMET00902 | DBMET00902 | |
| 0.005 | 0.742 | 0.039 | Integrin alpha5beta1 antagonist | 0.039 0.03 DBMET00902 | DBMET00902 | |
| 0.005 | 0.887 | 0.103 | Histone deacetylase class III inhibitor | 0.103 0.086 DBMET00902 | DBMET00902 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |